: Soliris. ?  »
|
-

I.V

Concentrate For Solution For Infusion

Soliris is indicated in adults and children for the treatment of patients with - Paroxysmal nocturnal haemoglobinuria (PNH).Evidence of clinical benefit of Soliris in the treatment of patients with PNH is limited to patients with history of transfusions.Eculizumab has not been studied in clinical trials in patients with PNH below 11 years of age.- Atypical haemolytic uremic syndrome (aHUS) .

144 09 32985 00

Alexion Pharma International Sarl, Switzerland

08/2010 - 07/2015

.
, .
.
/
Eculizumab 10 MG/ML
Vial 30 ml glass type i 1 x VIAL 30

*

*

 

.

 
" !
 

, .
:  »
301
-